MOA EbixA Pages on BioPortfolio:

Results from other life science and pharmaceutical sites:

15th Supervisory Board Meeting
Namenda/Ebixa. (Memantine). $642m. AChE inhibitors: Aricept, Exelon,Razadyne. $2566m(e) ... preclinical profile and MoA. Status: Phase I/II ...
http://www.evotec.com/uploads/cms_article/189/AM_280306_Webc...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.